VA to explore GLP-1 treatment for alcohol use disorder: 4 notes
The U.S. Department of Veterans Affairs is launching a clinical trial to evaluate whether semaglutide, a GLP-1 receptor agonist used to treat diabetes, can treat alcohol use disorder among veterans, according to a July 30 news release. The trial comes as evidence mounts that the drug has shown potential to reshape withdrawal management for substance […] The post VA to explore GLP-1 treatment for alcohol use disorder: 4 notes appeared first on Becker's Hospital Review | Healthcare News...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.